FindTrial
Sign In

Therapeutic schedule of deep infiltrating endometriosis based on the questionnaire - A prospective multicenter randomized controlled study

Therapeutic schedule of deep infiltrating endometriosis based on the questionnaire - A prospective multicenter randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009466
Enrollment
Unknown
Registered
2016-10-18
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deep infiltrating endometriosis

Interventions

intervention group:regular diagnosis combined with questionnaire
control group:regular diagnosis

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged at least 16 years and premenopause; 2. clincial diagnosis DIE; 3. untreated patient; 4. normal liver and kidney function, blood cell, urine examination.

Exclusion criteria

Exclusion criteria: Active infection; thrombosis history; Cardiovascular complications; Carcinoma;any illness patients who cannot be cooperated;

Design outcomes

Secondary

MeasureTime frame
recurrence time;operative complications;—

Primary

MeasureTime frame
EHP-30 questionnaire ;diagnose accordance rate;—

Countries

China

Contacts

Public ContactYu Wang

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

renjiwangyu@126.com+86 18918358318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026